Chapter 23: Cancer Genetics

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, usually when we talk about a medical diagnosis, there's this expectation of precision, like engineering or something.

Right, yeah, like a broken bone on an x -ray.

Exactly.

You break your arm, the x -ray shows that jagged white line, and the doctor just points and says, you know, there it is.

But back in 1969, two physicians, Frederick Paley and Joseph F.

Romany, they stumbled onto this medical mystery that completely defied that kind of clean binary logic.

It really did.

It was completely unprecedented at the time.

Yeah, they were combing through the I think 648 children who had a really rare muscle cancer, rubbed on myosarcoma.

And hidden in all that data, they found four families with wildly high rates of various cancers.

Right, it wasn't just one type.

No, we're talking breast cancer, brain tumors, bone cancer, soft tissue sarcomas.

It wasn't a predisposition to a specific type of cancer.

I mean, it was this massive overarching vulnerability to cancer in general.

Which is the absolute definition of diagnostic muddy waters.

I mean, most cancers just don't develop until much later in life, and the vast majority are not inherited.

Right.

But those four exceptional families completely changed our modern understanding of oncology.

They proved that cancer is fundamentally a genetic disease.

And if you are a college student staring down a massive genetics exam, that is the core concept you really have to master.

Definitely.

It's the foundation of everything in Chapter 23.

Yeah.

So today, we are not just going to memorize textbook vocabulary.

We are going to look under the hood of those families' DNA to understand exactly how a broken gene spirals into a tumor.

We're unpacking all the core logic of cancer genetics.

Right.

So what was actually happening in the DNA of those four families?

Well, what Lion From Any observed is a condition we now call, fittingly, Live From Any syndrome.

When geneticists actually mapped out the pedigrees of these families, a really clear pattern emerged.

Which was what, exactly?

This massive predisposition to cancer was being inherited as a simple autothermal dominant trait.

And decades of research finally revealed the specific culprit.

It was a single gene, right?

Yeah.

A germline mutation in a single gene called TP53.

This specific gene produces a protein known as P53, which is so crucial to function that it is literally referred to as the guardian of the genome.

The guardian of the genome.

I love that.

Let's unpack that title.

Because if you look at diagrams of how this protein operates, P53 sits at the center of this massive web, right?

Connecting to dozens of different biological processes.

It really is the ultimate cellular manager.

So P53 is a DNA binding protein.

It acts as a transcription factor, meaning it essentially turns other genes on or off.

Okay.

And its main job is to monitor the cell cycle, specifically regulating what's called the G1S checkpoint.

Right.

The checkpoint before DNA replication.

Exactly.

Before a cell copies its DNA to divide, P53 checks for damage.

If the DNA is damaged by, say, UV light or some chemical,

P53 slams the brakes on the cell cycle.

So it just freezes everything.

It halts everything before replication can even start, which gives the cell's repair mechanisms time to fix the broken DNA.

So it's essentially like a quality control inspector on an assembly line.

That's a perfect way to put it.

And if the damage is simply too severe to be fixed, P53 goes a step further and initiates apoptosis.

Programmed cell death.

Yes.

It basically forces the aberrant cell to dismantle itself from the inside out, safely removing it before it can multiply and pass on its broken genetic code.

Wow.

Yeah.

And by doing all this, it keeps the genome stable and prevents aneuploidy, which is when cells end up with the wrong number of chromosomes entirely.

Okay.

Let me play devil's advocate for a second here.

If every single person has a TP53 gene, is it accurate to say the gene causes cancer?

Oh, that's a great clarification.

Yeah.

No, the TP53 gene doesn't cause cancer at all.

It actively prevents it.

Right.

The vulnerability comes from the mutation or the total breakdown of this essential gene.

When P53 is defective, that vital G1S checkpoint is completely bypassed.

So the cell just ignores the damage?

Completely.

A cell with damaged DNA doesn't pause to repair itself and it doesn't self -destruct.

It just divides.

And then it divides again, right?

Just replicating those genetic errors over and over.

Exactly.

In fact, if you look at spontaneous human tumors across all types of cancer, about 50 % of them have mutations in the TP53 gene.

50%.

That's huge.

It is.

It shows just how critical that guardian really is.

Well, so if a cell is snowballing out of control because of broken DNA, that leads us to a pretty massive genetic paradox.

A big one, yeah.

Right.

If cancer is fundamentally driven by broken DNA, why isn't every single cell in our body cancerous?

And why do most cancers take decades to appear?

Early geneticists wrestled with that exact paradox because the evidence pointing to genetics was just undeniable.

Yeah.

I mean, we knew that carcinogens like radiation caused both mutations and cancer.

Right.

And we saw specific leukemias consistently linked to abnormal chromosomes.

And of course we saw syndromes like life from any running in families.

But as you said, if a person inherits a genetic mutation for cancer, every cell in their body carries that gene.

Exactly.

So why don't they just develop millions of tumors on day one?

And the solution to that paradox came in 1971, right?

From a researcher named Alfred Knudsen.

Yes, Knudsen.

He was studying retinoblastoma, which is a rare childhood eye cancer.

And his findings gave us the two -hit hypothesis.

So how does the two -hit hypothesis actually work?

Well, Knudsen realized that developing retinoblastoma requires two separate genetic defects.

So two independent hits at the exact same location in the DNA for the cancer to actually take off.

Okay.

He looked at two different pathways to prove this.

Sporadic cancer, which isn't inherited, and inherited cancer.

Let's start with the sporadic pathway.

I mean, how does a person with perfectly healthy genetics end up with eye cancer?

For a normal person, a single cell in one of their eyes must undergo a really rare somatic mutation.

That's hit number one.

But that's not enough on its own.

No, it's not.

That exact same cell or one of its direct descendants must eventually undergo a second completely independent somatic mutation at the exact same genetic locus.

Wow.

Yeah.

The statistical probability of one cell getting struck by genetic lightning twice in the exact same spot is incredibly low.

I would imagine.

Because it's so rare, it usually happens much later in life.

And it almost always affects only one eye.

It's unilateral.

But then you look at a child who inherits a germline mutation from a parent.

Yeah.

And in that case, every single cell in their body starts with that first hit.

And that completely changes the math.

They already have the first mutation on one chromosome in all of their millions of eye cells.

Right.

Now, they only one single somatic mutation on the other chromosome in any of those millions of cells.

So because you have millions of candidates, it just becomes a statistical near certainty.

Exactly.

It's almost guaranteed that at least one cell in each eye will acquire that second mutation.

This leads to early onset of the cancer and it usually affects both eyes.

Bilateral.

So inheriting a cancer predisposition doesn't mean you are born with cancer.

I mean, it means you are born starting halfway to the finish line of a terrible race.

You're just waiting for one more trip up.

That is a brilliant way to conceptualize it.

And while retinoblastoma is uniquely simple because it only requires two hits, we now know that most adult cancers require many more mutations across multiple different genes.

Which introduces the whole concept of clonal evolution, the snowball effect.

Precisely.

Imagine a single somatic cell gets a mutation that gives it a slight growth advantage.

It divides just a little bit

Okay, so it starts crowding them out.

Yeah.

Now you have a cloner, a small cluster of identical cells.

Because they are dividing constantly, their DNA polymerase is doing a lot more copying.

Which means they have a much higher statistical chance of making a typo.

Right.

Acquiring a second mutation.

And that second mutation might give them another superpower, like the ability to survive without normal nutrients or something.

Exactly.

That new

maybe allowing it to alter its physical structure.

Leveling up.

Yeah.

Then a fourth, giving it the ability to dissolve the cellular glue, holding it in place so it could invade other tissues, becoming truly malignant.

So through this process of clonal evolution, tumor cells just accumulate somatic mutations that make them increasingly aggressive.

They're effectively undergoing natural selection right inside the host's body.

Which brings us to the next big question, I think.

We know tumors evolve by accumulating mutations, but what is fueling this evolutionary arms race?

Right.

The environment plays a huge role here as an instigator.

There's that fascinating data on migrant populations in the textbook that proves this.

Oh, the epidemiological data is incredibly striking.

Historically, overall rates of colon cancer have been much lower in Japan than in Hawaii.

Right.

But when Japanese populations migrate to Hawaii within a single generation, their colon cancer rates rise to match or even exceed native Hawaiians.

And their underlying genetics obviously didn't change in one generation.

Exactly.

This proves that environmental factors, things like diet, tobacco use, obesity, or exposure to UV radiation,

are actively driving the mutation rates that fuel that clonal evolution.

So the environment acts as the instigator, pushing the mutation rate.

But what are the actual engines inside the cell that break down?

I mean, geneticists divide these broken engines into two main categories, right?

Yes, oncogenes and tumor suppressor genes.

The best way to understand them is to just imagine the cell cycle as a car.

Okay.

So normal healthy cells have genes that actively stimulate cell division, like a gas pedal.

Right.

Those are proto -oncogenes.

And they also have genes that inhibit cell division, the tumor suppressor genes, which are your breaks.

Okay.

Got it.

In a normal cell, you apply the gas and the breaks at the appropriate times to travel at the exact right speed.

But if a proto -oncogene mutates, it becomes an oncogene.

It's like the gas pedal gets stuck to the floor.

And if you're taking an exam on this, here is the critical trick to remember.

Oncogene mutations are dominant acting.

We all have two copies of every gene, one from each parent.

If just one of those alleles mutates into an oncogene, you've got a stuck gas pedal.

Right.

That single bad copy is enough to cause excessive cell proliferation.

But then contrast that with the tumor suppressor genes, the breaks.

Right.

Those mutations are generally recessive acting.

If one of your break lines fails, meaning one allele is mutated, you still have the other break line functioning perfectly fine.

So the normal unmutated allele produces enough tumor suppressing protein to keep the cell in check.

Exactly.

You need defects in both copies to completely lose your ability to stop the cell from dividing.

So let's tie this back to life from manny syndrome and that broken TP53 gene.

Inheriting one bad tumor suppressor allele means you're heterozygous.

Right.

You don't have cancer yet, but you are highly predisposed.

It's like flying a twin engine plane.

Inheriting a bad allele means you're born flying on only one engine.

That's a great way to look at it.

You can still fly perfectly fine.

But if a bird strikes your one remaining engine, a random somatic mutation,

you are in a complete freefall.

And geneticists call that the loss of heterozygosity.

If a random deletion or mutation happens on the chromosome carrying your one remaining normal copy of P53,

you suddenly have no working copies left.

You've lost your heterozygosity.

You've lost your breaks entirely and cell division just spirals out of control.

Okay.

So we understand the concept of a stuck accelerator, but how does that actually work on a molecular level?

How does a cell actually get told to divide and how does the message get corrupted?

Well, cells don't just divide randomly.

They respond to external signals called growth factors.

Right.

But a growth factor is usually a large molecule that can't easily phase through the cell membrane.

It binds to a receptor on the outside of the cell.

And that triggers something inside.

Yes.

This binding event triggers a cascade of chemical reactions inside the cell, a sort of molecular bucket brigade passing a message all the way down into the nucleus.

Yeah.

This is called a signal transduction pathway.

So if there's a defect anywhere in that bucket brigade, the cell might get a signal to divide even when there's no growth factor present at all.

Exactly.

The classic example is the RAS signal transduction pathway.

How does that one work?

When a growth factor binds to the receptor on the outside of the cell, the receptor physically changes shape.

This shape change allows adapter molecules inside the cell to grab onto a protein called RAS.

Okay.

Now normally RAS is inactive because it's tightly bound to a molecule called GDP.

It's just sleeping.

Right.

But when the adapter molecules poke it, RAS drops the GDP and picks up a highly energetic molecule called GTP.

Now it's awake.

And once RAS is active, it starts the chain reaction.

Yeah.

It triggers the next protein in line called RAF.

RAF wakes up and triggers another protein called MEK.

MEK triggers MEP kinase.

It's just a rapid fire cascade.

It is.

Mostly done by slapping phosphate groups onto the protein to change its shape.

Finally, activated MEP kinase travels straight into the nucleus and activates the transcription factors that turn on the genes for cell division.

Wow.

And then it turns off.

Yes.

Once the message is delivered,

normal RAS quickly burns off the energy in GTP, reverting back to its sleepy GDP state, turning the pathway off.

Okay.

So here is the terrifying breakdown.

If the RAS gene mutates into an oncogene, the resulting RAS protein literally loses its ability to turn off.

That's the problem.

It stays permanently bound to GTP.

It's permanently active.

It becomes a stuck doorbell, just sitting there screaming, divide, divide, down the pathway to the nucleus, even when there is absolutely no growth factor outside the cell.

The gas pedal is bolted to the floor.

And this isn't just a hypothetical model.

Mutations in RAS genes are found in roughly 95 % of all pancreatic tumors and 45 % of colorectal tumors.

95%.

It's an incredibly common driver of cancer, but there are other genetic culprits that fuel this evolution too.

We talked about DNA repair genes earlier.

Right.

If the genes responsible for spell checking our DNA mutate, like the BRCA1 gene in breast cancer, or the genes that cause xeroderma pigmentosum, the cell's repair machinery is broken.

Right.

That means typos in RAS or P53 are going to accumulate exponentially faster.

Then you have telomerase.

Right.

Normal somatic cells have a built -in biological clock.

They do.

Every time they divide, the protective caps on the ends of their chromosomes, called telomeres, get a little bit shorter, and eventually they get too short and the cell dies.

But cancer cells often mutate to inappropriately express telomerase, the enzyme that rebuilds those caps.

They essentially grant themselves biological

It's wild, but we also have to look beyond just the sequence of the DNA, right?

We have to consider epigenetics.

Absolutely.

Cancer cells frequently exhibit massive epigenetic changes, things like abnormal DNA methylation.

So like putting a molecular padlock on a gene.

Yes.

A cancer cell might incorrectly attach methyl groups to the promoter region of a tumor suppressor gene.

The actual DNA sequence of the brake line isn't mutated at all, but the padlock prevents the cell from reading it.

The brakes are silenced.

As researchers sequence entire cancer genomes, this presents a monumental challenge.

They have to sort through thousands of mutations and epigenetic changes to find out what's actually causing the disease.

It's the challenge of separating the driver mutations from the passenger mutations.

Right.

Think of a car crashing through a neighborhood.

The driver is the one actively causing the destruction.

That's your mutated RAS or P53 pushing the cancer forward.

But because the cell's repair mechanisms are broken,

thousands of random genetic typos happen that don't actually affect the cancer's growth.

Those are the passengers.

Just come along for the ride.

For targeted therapies to work, we have to isolate and target the drivers.

To see how all these invisible microscopic pieces connect in the real world, geneticists have mapped out the exact sequential timeline of specific cancers, right?

They have, yeah.

And the textbook uses colorectal cancer as the perfect model because it allows us to watch clonal evolution happen step by step over years.

Exactly.

Colorectal cancer typically begins as a small benign polyp that can actually be observed during a colonoscopy.

So what's step one?

The process usually kicks off when a normal cell lining the colon loses a specific tumor suppressor gene called APC.

So one brake line is cut.

The cell divides slightly faster than its neighbors, creating that small benign growth.

Then inside that polyp, one single cell acquires a second mutation.

The oncogene RAS is activated.

Yes.

Now you have a cut brake line and a stuck gas pedal.

That single cell divides aggressively, causing the polyp to grow into a larger precancerous adenoma.

Then the critical third strike happens.

A cell in that precancerous adenoma loses the TP53 tumor suppressor gene.

The guardian of the genome is gone.

It's gone.

The cell can no longer trigger apoptosis to save the surrounding tissue.

The adenoma transforms into a fully malignant carcinoma capable of invading the underlying muscle layer of the gut.

And finally, the cells undergo even further mutations,

including the loss of anti -metastasis genes.

Right.

They essentially dissolve the cellular glue that holds them in place, allowing the cancer cells to slip into the bloodstream and spread to the liver or lungs.

It's a terrifying observable timeline that perfectly unites Knudsen's multi -step model oncogenes and tumor suppressors.

It really synthesizes the entire progression.

But there is one final layer of complexity here.

Let's hear it.

Everything we've discussed so far involves tiny single gene mutations or epigenetic padlocks.

But if you look at an advanced cancer cell under a microscope, you'll see something much more chaotic.

The entire macroscopic structure of the chromosomes is often broken.

Right, aneuploidy.

Missing chromosomes, extra chromosomes, huge chunks torn off and glued to the wrong places.

For a long time, researchers weren't sure if this chromosomal chaos caused the cancer or if it was just the messy aftermath of the cancer.

It turns out it's a bit of both.

But there are highly specific chromosome rearrangements, massive structural changes like deletions, inversions, and translocations that definitively drive the cancer process.

There are two classic examples of reciprocal translocations that you will almost certainly see on a genetics exam, right?

Oh, definitely.

Let's break them down.

Example one is chronic myelogenous leukemia, or CML.

This involves a massive reciprocal translocation between chromosome 9 and chromosome 22.

They literally snap apart and trade pieces.

This specific trade creates a tiny, stunted chromosome 22 that geneticists call the Philadelphia chromosome.

But the danger isn't just that the pieces are on the wrong chromosomes, is it?

No.

The break happens right in the middle of two specific genes.

It tears the CABL gene off of chromosome 9 and fuses it directly to the BCR gene on chromosome 22.

So it creates a biological Frankenstein.

Exactly.

It creates a brand new mutant gene that doesn't exist in normal biology.

This new gene produces a BCR -CABL fusion protein, which is incredibly hyperactive.

It constantly stimulates cell division in white blood cells, driving the leukemia.

Wow.

Okay, so example two is Burkitt lymphoma.

This is another reciprocal translocation, but this time it's between chromosome 8 and chromosome 14.

This one doesn't create a Frankenstein fusion protein, though.

It uses a different trick.

It does.

It tears a potential cancer -causing proto -oncogene called CMYC off of chromosome 8 and drops it onto chromosome 14.

And it happens to drop it right next to the regulatory sequence that controls the production of immunoglobulins or antibodies.

And Burkitt lymphoma affects B cells, whose entire biological purpose is to operate as massive antibody factories.

Right.

So that regulatory sequence on chromosome 14 is constantly firing at maximum capacity, trying to pump out antibodies.

I see.

By dropping the CMYC gene right next to this hyperactive factory manager,

the B cell is tricked into massively overexpressing the CMYC protein instead.

This floods the cell with signals to divide, causing the lymphoma.

It's genetic hijacking.

It really is.

Which brings us to the final instigator of cancer.

Viruses.

Some viruses, like the human papillomavirus or HPV, literally operate by hijacking our cellular machinery.

Right.

Viruses survive by integrating their own DNA into the host's genome.

Sometimes a retrovirus will insert its DNA right next to a normal proto -oncogene.

And that messes it up.

Well, the virus brings its own highly active viral promoter, which accidentally kicks the host's proto -oncogene into overdrive, turning it into a pro -oncogene.

Oh, wow.

Other viruses produce specific viral proteins that directly bind to and disable the host's tumor suppressor proteins, like P53.

They actively cut the host cell's breaks so the cell is forced to continuously replicate the virus's DNA.

Wow.

We have covered a massive amount of ground today.

I mean, we started with those life -for -many families flying on a single P53 engine.

We broke down Nedson's two -hit hypothesis, watched the snowball effect of environmental factors step on the gas pedal of mutation.

We explored the dominant nature of oncogenes versus the recessive nature of tumor suppressors, traced the frantic bucket brigade of the Ras pathway, watched a single -cut brake line evolve into colorectal cancer, and broke down how massive chromosomal swaps create things like the Philadelphia chromosome.

If you're reviewing this for an exam, you now understand the underlying why and how behind the genetics, not just the vocabulary.

But before we wrap up, I want to leave you with one final thought to chew on.

We've spent this entire time talking about cancer as an evolutionary process happening inside our own bodies.

Tumors undergo clonal evolution, constantly adapting, mutating, and selecting for the most aggressive traits to survive our immune system and our chemotherapy.

Which begs a really fascinating question.

If a tumor is essentially an evolving ecosystem,

how might the principles of ecology and evolutionary biology be the key to designing future treatments?

That's a maximum toxic force, which sometimes just wipes out the weak cells and aggressively selects for the most resistant, unkillable clones.

What if the future of oncology isn't just about finding a bigger hammer, but learning how to manipulate the tumor's environment to outsmart its next evolutionary move?

Something to think about as you close the textbook today.

You've got this.

Thank you from the last -minute lecture team.